TY - JOUR T1 - Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: highly effective in a predominantly black male patient population JF - J Viral Hepat Y1 - 2018 A1 - Tang, L A1 - Parker, A A1 - Flores, Y A1 - et, al VL - 25 SP - 205-208 IS - 2 ER -